Research and Markets (http://www.researchandmarkets.com/reports/c32422) has announced the addition of Optimizing Sales Force Effectiveness: Using eHealth Applications to Improve the
Quality of Physician Interactions to their offering
Gaining access to influential healthcare professionals is difficult because physicians often do not have time to see drug reps during the working day. Furthermore, drug reps often fail to
make the most of the limited time they do have with prescribers. Over time this has caused drug reps to lose influence to patient requests during the prescribing process.
This title provides an introduction to the common challenges facing the pharmaceutical sales force in the US, the EU and Japan. It recommends how sales representatives can best use key
eHealth applications, such as eDetailing and eSampling, to improve access to physicians and identifies opportunities for pharmaceutical sales forces to be integrated into multi-channel
marketing campaigns. The report provides an analysis of future trends in sales force optimization.
The prescribing decisions of surveyed physicians are equally as likely to be affected by patient requests for specific mediations as they are to be affected by office visits from drug
reps.
The most effective way to influence word-of-mouth exchanges within the medical community is to provide a superior eDetailing experience. While this level of quality is what every pharma
company strives for, Our research shows that 35% of surveyed physicians rated the quality of recent eDetailing sessions as only average or below average.
We have found that an average of 44% of surveyed physicians cite "loss of personal interactions with sales representatives" as a factor that restricts the uptake of eDetailing services in
general.
For more information visit http://www.researchandmarkets.com/reports/c32422
Source: Datamonitor
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980